Medifast, Inc. (MED)

Market Cap	149.12M
Revenue (ttm)	602.46M
Net Income (ttm)	2.09M
Shares Out	10.66M
EPS (ttm)	0.19
PE Ratio	73.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	152,346
Open	13.61
Previous Close	13.68
Day's Range	13.50 - 14.06
52-Week Range	13.48 - 39.14
Beta	1.16
Analysts	Hold
Price Target	16.50 (+17.94%)
Earnings Date	Apr 28, 2025

About MED

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and sou...

• Industry: Personal Services
• Sector: Consumer Discretionary
• Founded: 1980
• Employees: 504
• Stock Exchange: NYSE
• Ticker Symbol: MED
• Website: https://medifastinc.com

Financial Performance

In 2024, Medifast's revenue was $602.46 million, a decrease of -43.80% compared to the previous year's $1.07 billion. Earnings were $2.09 million, a decrease of -97.90%.

Analyst Forecast

According to one analyst, the rating for MED stock is "Hold" and the 12-month stock price forecast is $16.5.

Price Target

$16.5

(17.94% upside)

Analyst Consensus: Hold